Cocrystal Pharma, Inc.COCPNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank71
3Y CAGR+40.8%
5Y CAGR+24.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+40.8%/yr
vs -13.4%/yr prior
5Y CAGR
+24.8%/yr
Recent acceleration
Acceleration
+54.2pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 2.16 | +243.0% |
| 2023 | 0.63 | +56.8% |
| 2022 | 0.40 | -48.1% |
| 2021 | 0.77 | -48.1% |
| 2020 | 1.49 | +109.2% |
| 2019 | 0.71 | -52.7% |
| 2018 | 1.51 | +9.8% |
| 2017 | 1.37 | -49.0% |
| 2016 | 2.69 | -19.7% |
| 2015 | 3.35 | - |